Andrew Wardley Selected Research

Andrew Wardley Research Topics

Disease

35	Breast Neoplasms (Breast Cancer) 12/2023 - 01/2005
9	Neoplasms (Cancer) 12/2023 - 01/2005
3	Heart Failure 12/2022 - 02/2007
3	Cardiovascular Diseases (Cardiovascular Disease) 02/2021 - 12/2005
3	Brain Neoplasms (Brain Tumor) 01/2021 - 02/2009
2	Triple Negative Breast Neoplasms 12/2023 - 12/2023
2	Fatigue 12/2023 - 01/2017
2	Cardiotoxicity 12/2022 - 12/2016
2	Disease Progression 05/2021 - 03/2010
2	Pathologic Complete Response 01/2019 - 01/2006
2	Neutropenia 01/2017 - 06/2013
2	Hypercholesterolemia 02/2007 - 12/2005
2	Uterine Hemorrhage (Uterine Bleeding) 02/2007 - 12/2005
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2022
1	Myocardial Ischemia (Ischemic Heart Diseases) 02/2021
1	Infections 01/2017
1	Febrile Neutropenia 05/2013
1	Hypertension (High Blood Pressure) 05/2013
1	Neoplasm Metastasis (Metastasis) 02/2009
1	Neurologic Manifestations (Neurological Manifestations) 02/2009
1	Central Nervous System Diseases (CNS Diseases) 02/2009
1	Bone Diseases (Bone Disease) 08/2008
1	Spontaneous Fractures (Pathological Fracture) 08/2008
1	Ischemia 02/2007
1	Arthralgia (Joint Pain) 02/2007
1	Hot Flashes 02/2007
1	Bone Fractures (Bone Fracture) 02/2007
1	Alopecia (Baldness) 01/2006
1	Thromboembolism 12/2005
1	Endometrial Neoplasms (Endometrial Cancer) 12/2005

Drug/Important Bio-Agent (IBA)

11	Trastuzumab (Herceptin)FDA Link 05/2021 - 01/2007
7	ErbB Receptors (EGF Receptor)IBA 05/2021 - 11/2009
7	Hormones (Hormone)IBA 02/2021 - 12/2005
6	Capecitabine (Xeloda)FDA Link 12/2023 - 01/2006
6	Letrozole (Femara)FDA LinkGeneric 02/2021 - 12/2005
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2023 - 01/2006
5	AnthracyclinesIBA 12/2022 - 05/2009
5	Tamoxifen FDA LinkGeneric 02/2021 - 12/2005
5	human ERBB2 proteinIBA 10/2020 - 11/2009
5	Docetaxel (Taxotere)FDA Link 05/2013 - 01/2006
4	Fluorouracil (Carac)FDA LinkGeneric 12/2023 - 05/2009
4	Epirubicin (Ellence)FDA LinkGeneric 12/2023 - 05/2009
4	Aromatase InhibitorsIBA 02/2021 - 12/2005
4	taxaneIBA 01/2013 - 01/2006
3	SteroidsIBA 11/2011 - 12/2005
2	Circulating Tumor DNAIBA 12/2023 - 01/2019
2	Methotrexate (Mexate)FDA LinkGeneric 12/2023 - 01/2017
2	tucatinibIBA 01/2021 - 10/2020
2	Bevacizumab (Avastin)FDA Link 06/2013 - 05/2013
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2013 - 01/2006
2	pertuzumabIBA 03/2010 - 03/2010
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 12/2023
1	Enalapril FDA LinkGeneric 12/2022
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2022
1	enzalutamideIBA 05/2021
1	Androgen Receptors (Androgen Receptor)IBA 05/2021
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2021
1	abemaciclibIBA 12/2020
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2019
1	ixabepilone (BMS 247550)FDA Link 06/2013
1	Paclitaxel (Taxol)FDA LinkGeneric 06/2013
1	Aromatase (CYP19)IBA 06/2012
1	ParaffinIBA 06/2012
1	Formaldehyde (Formol)FDA Link 06/2012
1	DNA (Deoxyribonucleic Acid)IBA 06/2012
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 07/2010
1	olaparibIBA 07/2010
1	Anastrozole (Arimidex)FDA LinkGeneric 11/2009
1	Lapatinib (GW572016)FDA Link 02/2009
1	Diphosphonates (Bisphosphonates)IBA 08/2008
1	Monoclonal AntibodiesIBA 01/2007
1	Taxoids (Taxanes)IBA 01/2006
1	Fulvestrant (Faslodex)FDA Link 01/2005

Therapy/Procedure

14	Therapeutics 12/2023 - 12/2005
8	Drug Therapy (Chemotherapy) 12/2022 - 01/2007
4	Adjuvant Chemotherapy 12/2023 - 01/2007
2	Neoadjuvant Therapy 12/2023 - 01/2019
2	Radiotherapy 02/2009 - 08/2008
1	Treatment Delay 12/2016
1	Intravenous Infusions 06/2013
1	Combination Drug Therapy (Combination Chemotherapy) 01/2013